Back to home
Business·

Spanish Office Invalidates Andorra Health Service's 'Programa de ayuda al triaje' Trademark

Andorra's public health service SAAS suffers another IP loss as Spain's OEPM invalidates its triage software trademark amid dispute with ex-ED head Dr. Gómez Jiménez.

Key Points

  • OEPM rules SAAS trademark M2587884 invalid due to lack of proven use since 2004 registration.
  • Esbarzer SL, linked to Dr. Josep Gómez Jiménez, successfully challenged the mark tied to Andorran Triage Model.
  • Legal disputes with Gómez Jiménez do not excuse non-use; software known as 'web_e-PAT', not exact mark.
  • Echoes EU Court annulment of related 'Sistema Estructurado de Triaje'; SAAS has one month to appeal.

The Spanish Patent and Trademark Office (OEPM) has declared the SAAS trademark "Programa de ayuda al triaje" (M2587884) invalid for lack of proven effective use, delivering another blow to Andorra's public health service in its long-running dispute with former Emergency Department head Dr. Josep Gómez Jiménez.

The ruling accepts a claim filed by Esbarzer SL, a company associated with Gómez Jiménez, against the mark registered in 2004 for software linked to the Andorran Triage Model. The OEPM dismissed SAAS arguments that ongoing legal battles with Gómez Jiménez and related firms excused the non-use, ruling that such conflicts do not justify abandoning the trademark. It further determined that no evidence showed use of the mark in its exact registered form, noting the software was typically known as "web_e-PAT".

This decision echoes an earlier ruling this year by the EU Court of Justice, which upheld the annulment of the related European trademark "Sistema Estructurado de Triaje". Sources near Gómez Jiménez's legal team and a statement from the doctor himself hailed the OEPM outcome as strengthening his position on rights to the triage system naming. They pointed out that two specialised bodies—the OEPM and the EU Intellectual Property Office—have now issued decisions against SAAS.

SAAS has one month to appeal the OEPM resolution. No further comments have emerged from the health service on potential next steps amid the wider litigation.

Share the article via